Vimarsana
Biggest News Aggregation in the World

Page 4 - Alanh Auerbach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alanh Auerbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alanh Auerbach Today - Breaking & Trending Today

Puma Biotechnology to Present at the H.C. Wainwright 25th Annual Global Investment Conference - Vimarsana News

Puma Biotechnology to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Puma Biotechnology, Inc. , a biopharmaceutical company , announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at...

Zacks Research Research Analysts Reduce Earnings Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) - Vimarsana News

Zacks Research Research Analysts Reduce Earnings Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI)

Puma Biotechnology, Inc. (NASDAQ:PBYI – Free Report) – Equities research analysts at Zacks Research decreased their Q2 2024 earnings per share (EPS) estimates for Puma Biotechnology in a note issued to investors on Thursday, August 17th. Zacks Research analyst K. Shah now forecasts that the biopharmaceutical company will post earnings per share of $0.06 for […]

Zacks Research Equities Analysts Cut Earnings Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) - Vimarsana News

Zacks Research Equities Analysts Cut Earnings Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI)

Puma Biotechnology, Inc. (NASDAQ:PBYI – Free Report) – Research analysts at Zacks Research decreased their Q2 2024 earnings per share estimates for shares of Puma Biotechnology in a research report issued on Thursday, August 17th. Zacks Research analyst K. Shah now expects that the biopharmaceutical company will earn $0.06 per share for the quarter, down […]

Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer - Vimarsana News

Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer

Puma Biotechnology, Inc. , a biopharmaceutical company, has been notified by the U.S. Food and Drug Administration that its Investigational New Drug submission has been reviewed, and Puma can...

Puma Biotechnology (NASDAQ:PBYI) Receives "Buy" Rating from HC Wainwright - Vimarsana News

Puma Biotechnology (NASDAQ:PBYI) Receives "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. They currently have a $8.00 price target on the biopharmaceutical company’s stock. Separately, StockNews.com lowered shares of Puma Biotechnology from a buy rating to a hold rating in […]